Rabbit Recombinant Monoclonal RED2 antibody. Suitable for WB, IHC-P and reacts with Mouse, Transfected cell lysate - Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
WB | IHC-P | ICC/IF | Flow Cyt | IP | |
---|---|---|---|---|---|
Human | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Mouse | Tested | Tested | Not recommended | Not recommended | Not recommended |
Rat | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Transfected cell lysate - Human | Tested | Not recommended | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/1000 | Notes - |
Species Transfected cell lysate - Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/2000 | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species Rat | Dilution info - | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species Transfected cell lysate - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Transfected cell lysate - Human, Human, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Transfected cell lysate - Human, Human, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Transfected cell lysate - Human, Human, Rat | Dilution info - | Notes - |
Select an associated product type
Lacks editing activity. It prevents the binding of other ADAR enzymes to targets in vitro, and decreases the efficiency of these enzymes. Capable of binding to dsRNA but also to ssRNA (By similarity).
ADARB1
Adar3, Red2, Adarb2, Double-stranded RNA-specific editase B2, RNA-dependent adenosine deaminase 3, RNA-editing deaminase 2, RNA-editing enzyme 2, dsRNA adenosine deaminase B2
Rabbit Recombinant Monoclonal RED2 antibody. Suitable for WB, IHC-P and reacts with Mouse, Transfected cell lysate - Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
RED1 and RED2 also known as RNA editing proteins are involved in the post-transcriptional modification of RNA molecules. RED1 has a molecular mass of approximately 60 kDa while RED2 weighs around 62 kDa. Both proteins are expressed in various tissues notably in the brain and liver where they function in RNA editing processes. These proteins participate actively in the editing of adenosine to inosine within RNA a critical step in processing RNA molecules for proper function.
RED1 and RED2 play key roles in the regulation of gene expression by influencing the maturation and stability of RNA transcripts. Both proteins are integral components of the RNA editing complex working with other editing enzymes to make precise modifications. Through their activity they affect the function and diversity of proteins encoded by the modified RNA impacting cellular mRNA landscapes and influencing coding potential.
RED1 and RED2 are significant contributors within the RNA-related regulatory pathways. Their editing activities are important in the RNA editing pathway impacting neuronal signaling and immune response pathways. These proteins interact with ADAR enzymes which help facilitate the conversion of adenosine to inosine in double-stranded RNA regions ensuring correct RNA sequence processing and function.
RED1 and RED2 have associations with neurodegenerative diseases and certain cancers. Aberrant RNA editing patterns involving these proteins are linked to Alzheimer's disease where disrupted RNA splicing and regulation occur. Furthermore cancerous growths often show altered expression of RED1 and RED2 connecting them to dysregulated cellular proliferation. These proteins interact with other key regulatory proteins like ADAR1 which also influences similar pathological pathways in these conditions.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking/Dilution buffer: 5% NFDM/TBST.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
This antibody weakly detects RED1 when high levels of recombinant protein of RED1 is over-loaded in Western Blot. Please apply the antibody with an optimized dilution.
In Western blot, anti-His antibody (Anti-6X His tag® antibody [EPR20547] - ChIP Grade ab213204) staining at 1/5000 dilution.
In Western blot, anti-GAPDH antibody (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) loading control staining at 1/200000 dilution.
All lanes: Western blot - Anti-RED1 + RED2 antibody [EPR26577-102] (ab307893) at 1/1000 dilution
Lane 1: 293T cells transfected with an empty vector containing a his tag whole cell lysate at 20 µg
Lane 2: 293T cells transfected with a human RED2 expression vector containing a his tag whole cell lysate at 20 µg
Lane 3: 293T cells transfected with a human RED1 expression vector containing a his tag whole cell lysate at 4 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Developed using the ECL technique.
Exposure time: 59s
Immunohistochemical analysis of paraffin-embedded mouse spleen tissue labeling RED2 with ab307893 at 1/2000 dilution (0.268 ug/ml) followed by a ready to use LeicaDS9800 (Bond® Polymer Refine Detection).
Negative control: No staining on mouse spleen.
The section was incubated with ab307893 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond® Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
Immunohistochemical analysis of paraffin-embedded mouse hippocampus tissue labeling RED2 with ab307893 at 1/2000 dilution (0.268 ug/ml) followed by a ready to use LeicaDS9800 (Bond® Polymer Refine Detection).
Positive staining on mouse hippocampus.
The section was incubated with ab307893 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond® Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
Blocking/Dilution buffer: 5% NFDM/TBST.
Negative control: spleen (PMID:31355950).
In Western blot, anti-H3 antibody (Anti-Histone H3 antibody [EPR16987] - Nuclear Marker and ChIP Grade ab176842) loading control staining at 1/100000 dilution.
Exposure time: 103 seconds.
All lanes: Western blot - Anti-RED1 + RED2 antibody [EPR26577-102] (ab307893) at 1/1000 dilution
Lane 1: Mouse cerebral cortex tissue lysate at 20 µg
Lane 2: Mouse spleen tissue lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 81 kDa
Observed band size: 80 kDa
Exposure time: 103s
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Lanes 1 - 3: Western blot - Anti-RED1 + RED2 antibody [EPR26577-102] (ab307893) at 1/1000 dilution
Lanes 1 - 3: Western blot - Anti-RED1 + RED2 antibody [EPR26577-102] - BSA and Azide free (Anti-RED1 + RED2 antibody [EPR26577-102] - BSA and Azide free ab307894)
Lane 1: 293T (Human embryonic kidney epithelial cell) +OE-empty at 20 µg
Lane 2: 293T (Human embryonic kidney epithelial cell) +OE-mouse RED2 at 20 µg
Lane 3: 293T (Human embryonic kidney epithelial cell) +OE-mouse RED1 at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 80 kDa
Exposure time: 10s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com